Related references
Note: Only part of the references are listed.Gene Therapy for Mucopolysaccharidosis Type II-A Review of the Current Possibilities
Pawel Zapolnik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Differences in MPS I and MPS II Disease Manifestations
Christiane S. Hampe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus
Jing Yong et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Endoplasmic Reticulum and Lysosomal Quality Control of Four Nonsense Mutants of Iduronate 2-Sulfatase Linked to Hunter's Syndrome
Alessandro Marazza et al.
DNA AND CELL BIOLOGY (2020)
Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses
Juan Camilo Losada Diaz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment
Francesca D'Avanzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Mutation severity spectrum of rare alleles in the human genome is predictive of disease type
Jimin Pei et al.
PLoS Computational Biology (2020)
Treatable lysosomal storage diseases in the advent of disease-specific therapy
Heidi Peters et al.
INTERNAL MEDICINE JOURNAL (2020)
Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II
Yosuke Osaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Modelling the neuropathology of lysosomal storage disorders through disease-specific human induced pluripotent stem cells
Julianna Kobolak et al.
EXPERIMENTAL CELL RESEARCH (2019)
Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain
Carolina Cardona et al.
HELIYON (2019)
Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer's disease
Yannis Gerakis et al.
FEBS JOURNAL (2018)
Hypothalamic ER associated degradation regulates POMC maturation, feeding, and age-associated obesity
Geun Hyang Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II
Yosuke Osaki et al.
CELL DEATH & DISEASE (2018)
The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase
Cathrine K. Fog et al.
EBIOMEDICINE (2018)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A. Hughes et al.
JOURNAL OF MEDICAL GENETICS (2017)
Epidemiology of mucopolysaccharidoses
Shaukat A. Khan et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications
Alessandra Biffi
MOLECULAR THERAPY (2017)
Open issues in Mucopolysaccharidosis type I-Hurler
Rossella Parini et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Insights into Hunter syndrome from the structure of iduronate-2-sulfatase
Mykhaylo Demydchuk et al.
NATURE COMMUNICATIONS (2017)
Chaperone effect of sulfated disaccharide from heparin on mutant iduronate-2-sulfatase in mucopolysaccharidosis type II
Hiroo Hoshina et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II
Francyne Kubaski et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation
G. Michael Preston et al.
BIOCHEMICAL JOURNAL (2017)
OS9 Protein Interacts with Na-K-2Cl Co-transporter (NKCC2) and Targets Its Immature Form for the Endoplasmic Reticulum-associated Degradation Pathway
Elie Seaayfan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Tay-Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum-associated degradation
Devin Dersh et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
N-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding Cycle
Lydia Lamriben et al.
TRAFFIC (2016)
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
Aya Narita et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases
Seiji Saito et al.
PLOS ONE (2016)
Hematopoietic Cell Transplantation for Mucopolysaccharidosis Patients Is Safe and Effective: Results after Implementation of International Guidelines
Mieke Aldenhoven et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease
Inna Sabirzhanova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
Giancarlo Parenti et al.
MOLECULAR THERAPY (2015)
Robust Endoplasmic Reticulum-Associated Degradation of Rhodopsin Precedes Retinal Degeneration
Wei-Chieh Chiang et al.
MOLECULAR NEUROBIOLOGY (2015)
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients
Rossella Parini et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2015)
ERdj3 Is an Endoplasmic Reticulum Degradation Factor for Mutant Glucocerebrosidase Variants Linked to Gaucher's Disease
Yun Lei Tan et al.
CHEMISTRY & BIOLOGY (2014)
Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease
Taichi Hara et al.
SCIENTIFIC REPORTS (2014)
The Association of the Vanin-1 N131S Variant with Blood Pressure Is Mediated by Endoplasmic Reticulum-Associated Degradation and Loss of Function
Ya-Juan Wang et al.
PLOS GENETICS (2014)
Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome)
Young Bae Sohn et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: A nationwide survey in Japan
Akemi Tanaka et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Idursulfase treatment of Hunter syndrome in children younger than 6 years: Results from the Hunter Outcome Survey
Joseph Muenzer et al.
GENETICS IN MEDICINE (2011)
Lysosomal storage diseases: Diagnostic confirmation and management of presymptomatic individuals
Raymond Y. Wang et al.
GENETICS IN MEDICINE (2011)
Natural Progression of Neurological Disease in Mucopolysaccharidosis Type II
Joshua B. Holt et al.
PEDIATRICS (2011)
Clearance of RhodopsinP23H aggregates requires the ERAD effector VCP
Ana Griciuc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions
Vinod K. Prasad et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Protein quality control in the ER: The recognition of misfolded proteins
Pekka Maattanen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Gaucher disease:: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Kathleen S. Hruska et al.
HUMAN MUTATION (2008)
Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity:: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin
Satoshi Ishii et al.
BIOCHEMICAL JOURNAL (2007)
Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: Enzymatic activity, protein processing and structural analysis
K. Sukegawa-Hayasaka et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer et al.
GENETICS IN MEDICINE (2006)
Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus
N Marr et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening
JL Bobadilla et al.
HUMAN MUTATION (2002)
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor
H Yoshida et al.
CELL (2001)
Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia
CA Mullen et al.
BONE MARROW TRANSPLANTATION (2000)
Sodium 4-phenylbutyrate downregulates Hsc70:: implications for intracellular trafficking of ΔF508-CFTR
RC Rubenstein et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2000)
Share Paper
